Music Therapy for Labor Pain and Anxiety

August 17, 2025 updated by: Nesrine Souayeh, University Tunis El Manar

Impact of Music Therapy on Labor Pain and Anxiety: A Randomized Controlled Trial in Tunisian Women

This multicenter randomized controlled trial evaluates the effectiveness of music therapy in reducing pain and anxiety during the latent and active phases of labor in Tunisian women. Participants are randomized to receive either music therapy or standard care. Primary outcomes are pain (VAS) and anxiety (STAI-Y). Secondary outcomes include labor duration, maternal and fetal vital signs, neonatal outcomes, and maternal satisfaction.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study investigates the impact of music therapy on pain and anxiety management during labor in Tunisian parturients. Given the limited access to pharmacological analgesia in many public maternity units, the trial explores music as a non-pharmacological, low-cost, and patient-centered intervention. Eligible women in labor are randomly assigned to either a music therapy group or a control group receiving standard care. Music is administered during the latent and active phases following established clinical guidelines (slow tempo, non-lyrical, patient-guided selection). The study evaluates changes in pain intensity, anxiety levels, labor progression, maternal-fetal physiological parameters, neonatal outcomes, and maternal satisfaction. Findings aim to inform labor care practices and promote integrative approaches in resource-limited settings.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ben Arous, Tunisia, 2096
        • Ben Arous regional Hospital
        • Contact:
        • Principal Investigator:
          • Oumaima Marzouki, Master's Student

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Married Tunisian women with a singleton, low-risk pregnancy.
  • Admitted in the latent phase of spontaneous labor, as diagnosed by a midwife or resident.
  • Planned vaginal delivery.
  • Parity < 4.
  • Gestational age between 37 and 41 weeks of amenorrhea.
  • Attended at least 4 prenatal consultations.
  • Normal physical and mental health status.
  • No known fetal anomalies.
  • Estimated fetal weight between 2500-4000 g.
  • Cephalic presentation.
  • Normal fetal heart rate and uterine contraction tracings.
  • Able to read, write, and understand study-related information.
  • Provided written informed consent.

Exclusion Criteria:

  • Women who received epidural analgesia during labor.
  • Presence of auricular malformations.
  • Difficulty in understanding or completing the VAS or STAI-Y assessments.
  • Serious medical or psychiatric disorders.
  • Multiple gestation or pregnancies requiring immediate intervention.
  • Preterm (<37 weeks) or post-term (>41 weeks) pregnancies.
  • Premature rupture of membranes.
  • Clinical chorioamnionitis or other infections (including HIV).
  • History of severe obstetric complications (e.g., cephalopelvic disproportion, intrauterine fetal death )

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Music group
The intervention consists of music therapy administered during the latent and active phases of labor. Music is delivered through headphones or speakers and includes slow, instrumental, non-lyrical tracks (60-80 beats per minute), selected in collaboration with the participant. The intervention is applied for a minimum duration of 30 minutes and follows established clinical guidelines for therapeutic music use. Standard monitoring of maternal and fetal well-being is maintained throughout the intervention.
This intervention involves the use of patient-selected, slow-tempo (60-80 bpm), non-lyrical instrumental music administered via headphones or speakers during the latent and active phases of labor. The music selection is guided to ensure therapeutic suitability (e.g., calming rhythm, absence of lyrics) and is delivered for a minimum of 30 minutes. The intervention is non-pharmacological, individualized, and adheres to WHO and clinical music therapy recommendations. It is distinguished by its personalized music choice, delivery timing, and structured application within labor progression monitoring.
No Intervention: Control Group

This group received routine care during labor (monitoring of labor progression, vital signs, and fetal heart rate monitoring).

No specific pain management techniques were used for this group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level
Time Frame: 30 minutes after completing the music session
Pain intensity will be measured using a 10-cm Visual Analogue Scale (VAS), ranging from 0 = no pain to 10 = worst imaginable pain.
30 minutes after completing the music session
Anxiety level
Time Frame: 30 minutes after completing the music session
Anxiety level will be measured using the State-Trait Anxiety Inventory, Form Y (STAI-Y), with higher scores indicating greater anxiety.
30 minutes after completing the music session

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal pulse rate
Time Frame: 30 minutes after completing the music session
Maternal pulse rate will be maesured in beat per minute 30 mn after listening to the musioc selection
30 minutes after completing the music session
Maternal arterial pressure
Time Frame: 30 minutes after completing the music session
Maternal arterial pressure will be maesured in mmHg
30 minutes after completing the music session
Apgar score
Time Frame: 5 minutes after delivery
the foetal pgar score was maesures on a scale from 0 to 10 five minutes after delivery
5 minutes after delivery
Maternal satisfaction
Time Frame: 2 hours after delivery
Maternal satisfaction was maesured by a likert scale from 1 to 10 2 hours after delivery
2 hours after delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2025

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

August 17, 2025

First Submitted That Met QC Criteria

August 17, 2025

First Posted (Actual)

August 24, 2025

Study Record Updates

Last Update Posted (Actual)

August 24, 2025

Last Update Submitted That Met QC Criteria

August 17, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 03/2025 (Registry Identifier: EK Český Těšín)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Individual participant data (IPD) will not be shared because of concerns regarding patient confidentiality and the absence of institutional infrastructure for secure data sharing.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Music Therapy During Labor

Subscribe